Here’s what you should know:
1. He implanted a device called the Hydrus Microstent.
2. Dr. Endl performed the procedure at the Niagara Falls, N.Y.-based Ambulatory Surgery Center of Niagara.
3. The Hydrus Microstent received FDA approval in August.
More articles on supply chain:
Providers have power to help mistreated surgical equipment makers, study says: 6 insights
Takeda expected to win EU approval for Shire deal — Shareholder vote last hurdle
ASC supply chain tip of the day: Check your data
